ABT vs. BAX: Abbott Laboratories vs. Baxter Stock Comparison
How do Abbott Laboratories (ABT) and Baxter (BAX) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Abbott Laboratories (ABT) and Baxter (BAX) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | ABT | BAX |
|---|---|---|
| Name | Abbott Laboratories | Baxter International Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 190.39 billion USD | 13.34 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 17, 1980 | October 27, 1981 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ABT | BAX |
|---|---|---|
| Total Return (1Y) | -10.78% | 45.72% |
| Total Return (3Y, Annualized) | 7.79% | -5.53% |
| Total Return (5Y, Annualized) | -0.79% | -17.96% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ABT | BAX |
|---|---|---|
| Volatility (1Y, Annualized) | 28.48% | 42.31% |
| Beta (5Y) | 0.53 | 0.62 |
| Max Drawdown (5Y) | -39.64% | -80.61% |
| Avg. Volume (3M) | 8.74M | 6.53M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ABT | BAX |
|---|---|---|
| Sharpe Ratio (1Y) | -0.53 | 0.98 |
| Sortino Ratio (1Y) | -0.76 | 1.42 |
Profitability
ROE (TTM)
Baxter (BAX) reports a negative ROE of -9.04%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Abbott Laboratories (ABT) reports 9.14%, ranking against industry peers normally.
ABT
Health Care Equipment & Services industry group
9.14%
- Max
- 47.61%
- Q3
- 14.36%
- ABT
- 9.14%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
BAX
Health Care Equipment & Services industry group
-9.04%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- BAX
- -9.04%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Baxter (BAX) reports a negative net margin of -6.23%, usually indicating a net loss over the period. Meanwhile Abbott Laboratories (ABT) reports 9.75%, ranking against industry peers normally.
ABT
Health Care Equipment & Services industry group
9.75%
- Max
- 29.35%
- ABT
- 9.75%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
BAX
Health Care Equipment & Services industry group
-6.23%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- BAX
- -6.23%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Abbott Laboratories (ABT) at 11.66% and Baxter (BAX) at 9.88% run core operations about as efficiently as their industries’ norm — neither stands out on operating profitability.
ABT
Health Care Equipment & Services industry group
11.66%
- Max
- 35.43%
- Q3
- 14.14%
- ABT
- 11.66%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
BAX
Health Care Equipment & Services industry group
9.88%
- Max
- 35.43%
- Q3
- 14.14%
- BAX
- 9.88%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | ABT | BAX |
|---|---|---|
| ROE (TTM) | 9.14% | -9.04% |
| ROA (TTM) | 4.90% | 2.71% |
| Net Margin (TTM) | 9.75% | -6.23% |
| Operating Margin (TTM) | 11.66% | 9.88% |
| Gross Margin (TTM) | 57.17% | 33.37% |
Growth
Revenue Growth
Both Abbott Laboratories (ABT) at 5.67% and Baxter (BAX) at 5.72% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Only one side can be read here: Abbott Laboratories (ABT) reports EPS growth of -51.31%, ranked against its industry; Baxter (BAX) has no EPS growth figure this period.
Growth Metrics
| Metric | ABT | BAX |
|---|---|---|
| Revenue Growth (YoY) | 5.67% | 5.72% |
| Revenue Growth (3Y CAGR) | 0.51% | 3.79% |
| EPS Growth (YoY) | -51.31% | -- |
| EPS Growth (3Y CAGR) | -1.65% | -- |
Financial Strength
Current Ratio (MRQ)
Both Abbott Laboratories (ABT) at 1.46 and Baxter (BAX) at 1.79 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
ABT
Health Care Equipment & Services industry group
1.46
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- ABT
- 1.46
- Q1
- 1.37
- Min
- 0.30
BAX
Health Care Equipment & Services industry group
1.79
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- BAX
- 1.79
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Abbott Laboratories (ABT) at 0.61 carries an industry-typical debt-to-equity mix, while Baxter (BAX) at 1.36 uses more debt funding than most peers.
ABT
Health Care Equipment & Services industry group
0.61
- Max
- 1.88
- Q3
- 0.91
- ABT
- 0.61
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
BAX
Health Care Equipment & Services industry group
1.36
- Max
- 1.88
- BAX
- 1.36
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | ABT | BAX |
|---|---|---|
| Current Ratio (MRQ) | 1.46 | 1.79 |
| Debt / Equity (MRQ) | 0.61 | 1.36 |
| Net Debt / EBITDA | 2.37 | 3.73 |
Dividends
Dividend Yield (TTM)
Both Abbott Laboratories (ABT) at 2.22% and Baxter (BAX) at 0.16% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
ABT
Health Care Equipment & Services industry group
2.22%
- ABT
- 2.22%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
BAX
Health Care Equipment & Services industry group
0.16%
- BAX
- 0.16%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Baxter (BAX) reports payout ratio above 100% at 154.67%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile Abbott Laboratories (ABT) reports 92.54%, ranking against industry peers normally.
ABT
Health Care Equipment & Services industry group
92.54%
- ABT
- 92.54%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
BAX
Health Care Equipment & Services industry group
154.67%
- BAX
- 154.67%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ABT | BAX |
|---|---|---|
| Dividend Yield (TTM) | 2.22% | 0.16% |
| Dividend Payout Ratio (TTM) | 92.54% | 154.67% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: Abbott Laboratories (ABT) trades at 41.02 times trailing earnings, ranked against its peers, while Baxter (BAX) has no P/E ratio this period.
ABT
Health Care Equipment & Services industry group
41.02
- Max
- 80.41
- Q3
- 47.62
- ABT
- 41.02
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
BAX
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- BAX
- --
P/S Ratio (TTM)
On P/S ratio, both Abbott Laboratories (ABT) at 3.95 and Baxter (BAX) at 1.15 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
ABT
Health Care Equipment & Services industry group
3.95
- Max
- 8.80
- Q3
- 4.32
- ABT
- 3.95
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
BAX
Health Care Equipment & Services industry group
1.15
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- BAX
- 1.15
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Abbott Laboratories (ABT) at 3.73 and Baxter (BAX) at 2.05 are valued close to their industries’ norm against book — neither stands out from peers.
ABT
Health Care Equipment & Services industry group
3.73
- Max
- 11.68
- Q3
- 6.12
- ABT
- 3.73
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
BAX
Health Care Equipment & Services industry group
2.05
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BAX
- 2.05
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | ABT | BAX |
|---|---|---|
| P/E Ratio (TTM) | 41.02 | -- |
| P/S Ratio (TTM) | 3.95 | 1.15 |
| P/B Ratio (MRQ) | 3.73 | 2.05 |
| Free Cash Flow Yield (TTM) | 3.19% | 9.16% |